This study is set up to assess the feasibility and safety of the clinical procedure using AneuFix in a prophylactic setting at the time of EVAR endograft implantation.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Asymptomatic, infrarenal AAA that requires surgery with a high-risk profile of developing endoleak type II in line with the recommendations of Guntner et al:
\- Open IMA AND
* 1 patent lumbar AND a cross-sectional area at the location of the IMA (CSAIMA) \>17,5cm2 OR
* 2 patent lumbars AND a CSAIMA \>15cm2 OR
* 3 patent lumbars AND a CSAIMA \>12,5 cm2 OR
* 4 patent lumbars AND a CSAIMA \>10 cm2 OR
* 5 patent lumbars AND a CSAIMA \>7,5 cm2
* Infrarenal neck according to the IFU of the EVAR device
* Other aortic-iliac anatomical configuration suitable for EVAR according to the criteria of the EVAR device to be used
* Patient having a life expectation of at least 2 years
* Being older than 18 years
* Willing and able to comply with the requirements of this clinical study
Exclusion Criteria:
* Patient not able or willing to give written Informed Consent
* Patient undergoing emergency procedures
* Patient undergoing EVAR for ruptured or symptomatic AAA,
* Patient with a suprarenal AAA
* Patient with an inflammatory AAA (more than minimal wall thickening)
* Patient with an infrarenal neck unsuitable for endovascular fixation (including so called "hostile necks") or aortic-iliac anatomic configuration otherwise unsuitable for EVAR according to criteria of the device to be used
* Patient in which a bilateral retroperitoneal incision is required for EVAR
* Patient in which a sacrifice of both hypogastric arteries is required
* Patient with anatomi…